CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.675
AS - Asia 3.642
EU - Europa 2.386
SA - Sud America 546
AF - Africa 77
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.352
Nazione #
US - Stati Uniti d'America 6.551
SG - Singapore 1.407
CN - Cina 914
IT - Italia 662
DE - Germania 460
VN - Vietnam 436
BR - Brasile 424
UA - Ucraina 345
HK - Hong Kong 283
FI - Finlandia 238
TR - Turchia 216
GB - Regno Unito 201
FR - Francia 129
SE - Svezia 98
RU - Federazione Russa 85
JP - Giappone 82
IN - India 67
MX - Messico 62
BD - Bangladesh 49
CA - Canada 49
ID - Indonesia 44
AR - Argentina 42
NL - Olanda 36
PL - Polonia 36
ZA - Sudafrica 30
IQ - Iraq 23
EC - Ecuador 20
BE - Belgio 17
PK - Pakistan 17
AU - Australia 16
ES - Italia 15
MA - Marocco 14
VE - Venezuela 14
LT - Lituania 13
PH - Filippine 13
CO - Colombia 12
UZ - Uzbekistan 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
MY - Malesia 9
AT - Austria 8
TN - Tunisia 8
CL - Cile 7
NP - Nepal 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
KE - Kenya 6
PE - Perù 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EG - Egitto 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
HR - Croazia 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LI - Liechtenstein 1
ME - Montenegro 1
Totale 13.341
Città #
Singapore 865
Ashburn 702
Fairfield 641
Woodbridge 556
San Jose 399
Houston 391
Jacksonville 380
Santa Clara 310
Ann Arbor 281
Chandler 279
Hong Kong 279
Beijing 276
Munich 256
Seattle 241
Wilmington 220
Cambridge 205
Washington 199
Ho Chi Minh City 141
Izmir 138
Helsinki 125
Nanjing 123
Los Angeles 104
Hanoi 100
Milan 97
Dallas 90
Princeton 86
New York 82
Tokyo 79
Lauterbourg 73
Ferrara 72
Boardman 56
Rome 44
San Diego 43
Chicago 41
Mexico City 37
Shanghai 37
Dearborn 35
Warsaw 33
Addison 31
Council Bluffs 31
São Paulo 31
Jakarta 30
Nanchang 29
Orem 29
Turku 28
Shenyang 27
Hebei 26
Tianjin 25
Brooklyn 21
Buffalo 21
Da Nang 21
Toronto 21
Hefei 20
Jiaxing 20
Frankfurt am Main 19
London 19
Cardiff 18
Changsha 18
Haiphong 18
Chennai 17
Denver 16
Guangzhou 16
Moscow 16
Mountain View 16
Hải Dương 15
Kunming 15
Atlanta 14
Bologna 14
Brussels 14
Johannesburg 14
Montreal 14
Bremen 13
Parma 13
Boston 12
Florence 12
Manchester 12
Naples 12
Redwood City 12
Auburn Hills 11
Jinan 11
Rio de Janeiro 11
Belo Horizonte 10
Blackpool 10
Campinas 10
Jyväskylä 10
San Francisco 10
Taizhou 10
The Dalles 10
Verona 10
Amsterdam 9
Baghdad 9
Curitiba 9
Dong Ket 9
Falls Church 9
Norwalk 9
Ningbo 8
Nuremberg 8
Orange 8
Salt Lake City 8
Stockholm 8
Totale 9.093
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 445
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 337
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 335
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 301
Targeting Th2 cells in asthmatic airways 297
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 274
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 251
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 211
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 209
Activation of NF-kappaB transcription factor in asthma death 204
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 203
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 200
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 199
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 199
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 197
Cellule staminali e patologia polmonare dell’adulto 196
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 188
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 187
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 179
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 176
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 175
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 174
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 172
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 170
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 163
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 163
Mechanisms involved in lung cancer development in COPD 162
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 161
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 161
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 161
Pathophysiology of viral-induced exacerbations of COPD 155
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 154
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 154
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 153
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 148
COPD immunopathology 148
New drugs targeting Th2 lymphocytes in asthma 145
Increased deposition of activated complement in peripheral lung vessels of smokers 144
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 142
COPD pathology in the small airways 141
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 137
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 135
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 131
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 126
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 125
null 121
null 118
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 118
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 117
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 116
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 115
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 114
null 114
Trattamento personalizzato dei pazienti con BPCO in fase stabile 114
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 112
SAA and lipid metabolism in IPF 108
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 106
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 105
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 104
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 103
null 102
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 102
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 101
Expression of adenosine receptors in the peripheral lung from COPD patients. 100
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 99
Scavenger Receptor B1 involvement in COPD pathogenesis 94
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1 94
Definition and aetiology of infective exacerbations of COPD 93
null 92
null 91
null 91
null 90
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 90
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 89
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 88
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 88
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 88
null 88
null 88
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 83
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 83
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 82
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 82
null 81
null 81
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 81
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 77
null 66
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 59
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 54
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 53
null 51
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 50
Role of transcription factors in the pathogenesis of asthma and COPD 47
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 41
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD 19
Totale 13.512
Categoria #
all - tutte 56.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.535
Totale 59.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021378 0 0 0 0 0 0 0 0 0 135 132 111
2021/2022730 26 71 70 54 24 36 26 49 22 58 85 209
2022/2023731 91 21 25 92 120 107 32 61 95 3 54 30
2023/2024353 39 45 14 6 28 55 10 17 6 10 12 111
2024/20252.025 42 52 141 49 234 223 138 154 368 214 224 186
2025/20264.892 447 238 447 616 835 291 611 370 513 524 0 0
Totale 13.512